This ICR collects information from
device manufactures and distributors who are subject to the
requirements for device tracking, tracking systems, and distributor
reporting. Manufacturers must track a class II or class III device
if its failure would be reasonable likely to have serious adverse
health consequences, or it is intended to be implanted in the human
body for more than one year, or it is life-sustaining or
life-supporting and used outside a device user facility, or when
FDA determines that tracking would be appropriate in order to
protect the general public in the event of a device
recall.
Upon review of this ICR under
the PRA, the burden for "Tracking information-821.25(a)" has been
changed from reporting to recordkeeping. This resulted in an
adjustment of the reporting burden being decreased by 17,911. As a
result of parsing out estmiates for the different ICs, the number
of respondents has increased.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.